Time to HIV viral rebound and post-treatment controller in HIV cure studies with treatment interruptions
By Dr Jesper D Gunst, Dr Jesal Gohil, Dr Ole S Sogaard, Dr Sarah Fidler Researchers from Denmark and The
clinical trial
Managing hope and expectation: Perspectives on HIV cure
HIV cure. Those two little words elicit such hope, expectation and frustration. This was the theme that ran through the
Maintaining momentum: HIV cure research in the COVID era
The COVID-19 pandemic has devastated lives, healthcare systems and economies around the world. Research has not escaped unscathed. Clinical trials
HIV cure snapshot
The Australasian HIV&AIDS Conference (commonly known as ASHM after the organiser, the Australasian Society for HIV Medicine) was held online
Towards Meaningful Engagement in Melbourne
Background In 2018, the Victorian Government Department of Health and Human Services announced $1.2 million funding to establish the Melbourne
Pausing the pills: attitudes to treatment interruption
Participants in HIV cure trials will increasingly need to consider stopping antiretroviral treatment. This will be the only sure way
INSPIRING a new generation of community-minded HIV researchers
A new project seeks to put the principles of community involvement in research into action. The INSPIRE project has been funded
Don’t believe the hype: Gammora is not an HIV cure
With the internet and a twitter account, spreading information is easy. When it comes to HIV cure research, it can
Joining the search for a cure
This article was originally published in the Spring 2018 issue of Poslink, the newsletter of Living Positive Victoria. Have you
Stigma, seroconversion and the search for an HIV cure
Reducing the persistent stigma and discrimination related to HIV infection drives clinician scientist Jintanat Ananworanich. Her research interests range from
HIV research hinges on people living with HIV
This article was originally published in HIV Australia, the publication of the Australian Federation of AIDS Organisations Since it exploded
VIVA trial: Vitamin D in HIV latency
The current standard treatment for people living with HIV is a combination of drugs known as antiretroviral therapy (or ART).